Table 1.
Author | Age at diagnosis | Sex | Family history | Followup age/status |
Cardiovascular findings | Treatment |
---|---|---|---|---|---|---|
Gleason et al. [2] | 5 years | M | No | 5 years/D | CHF | None |
Gleason et al. [2] | 2 months | M | Yes | 5 years/A | NA | Steroid Thyroid estrogen |
Gleason et al. [2] | Birth | F | Yes | 3 years/A | None | Diphosphonates |
Gleason et al. [2] | 2 weeks | F | No | 7 years/A | Pulmonary stenosis | None |
Gleason et al. [2] | 3 weeks | F | No | 22 years/A | Angina; myocardial infarction | Digoxin Disopyramide |
Gleason et al. [2] | 10 days | M | No | 2 years/A | CHF, HT | Diphosphonates Digoxin |
Gleason et al. [2] | Birth | M | Yes | 6 years/A | Arterial calcifications | Digoxin Diuretics |
Rutsch et al. [3] | 5 days | M | Yes | 2,5 years/A | CHF | Antifailure Diphosphonates |
Sebire and Sheppard [4] | 11 years | F | No | 11 years/D* | CHF | Dobutamine |
Patel et al. [5] | 2,5 years | F | No | 4,5 years/A | Headaches; failure to thrive | Anti-failure |
van der Sluis et al. [6] | Birth | M | Yes | 25 years/A | None | Diphosphonates |
Our case (2008) | 5 years | F | No | 5 years/D* | CHF | None |
CHF: cardiac heart failure; HT: hypertension; A: Alive; D: Dead; NA: nonavailable; *Acute myocardial infarction.